AKR1C3

 Aldo-keto reductase family 1 member C3 (AKR1C3), also known as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5, HSD17B5) is a key steroidogenic enzyme that in humans is encoded by the AKR1C3 gene.[5][6][7]

AKR1C3
Protein AKR1C3 PDB 1ry0.png
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesAKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS, aldo-keto reductase family 1, member C3, aldo-keto reductase family 1 member C3
External IDsOMIM603966 MGI2145420 HomoloGene128661 GeneCardsAKR1C3
EC number1.3.1.20
Gene location (Human)
Chromosome 10 (human)
Chr.Chromosome 10 (human)[1]
Chromosome 10 (human)
Genomic location for AKR1C3
Genomic location for AKR1C3
Band10p15.1Start5,035,354 bp[1]
End5,107,686 bp[1]
RNA expression pattern
PBB GE AKR1C3 209160 at fs.png

PBB GE AKR1C1 211653 x at fs.png
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003739
NM_001253908
NM_001253909

NM_134066
NM_001346535

RefSeq (protein)

NP_001240837
NP_001240838
NP_003730

NP_001333464
NP_598827

Location (UCSC)Chr 10: 5.04 – 5.11 MbChr 13: 4.13 – 4.15 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

FunctionEdit

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin D2prostaglandin H2, and phenanthrenequinone, and the oxidation of prostaglandin F to prostaglandin D2.[7] It is also capable of metabolizing estrogen and progesterone.[8]

AKR1C3 may play an important role in the development of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14.[7]

PathologyEdit

AKR1C3 is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). In addition, AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.[9]

This article uses material from the Wikipedia article
 Metasyntactic variable, which is released under the 
Creative Commons
Attribution-ShareAlike 3.0 Unported License
.